OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AHRNYSE63

American Healthcare REIT, Inc.

Specialized REITsVerified

American Healthcare REIT, Inc. (AHR) is currently classified as Specialized REITs within Specialized REITs (Real Estate). Classification confidence: 0.92 (verified market data). Capital structure on the latest snapshot: total assets 5,426,226,000 USD, total equity 3,320,638,000, short-term debt 0, long-term debt 0. Net cash position is approximately 114,836,000 USD. Profitability profile: revenue 2,094,506,000, gross profit 0, operating income 415,160,000, net income 69,806,000. Return on equity ~2.1%. Return on assets ~1.3%. Operating-cash-flow to net-income ratio is 4.22. Risk profile from automated assessment: liquidity risk low, dilution risk medium. Flags: Source documents mention dilution or offering risk..

30-day price · AHR+1.09 (+2.2%)
Low$46.68High$52.45Close$49.94As of18 May, 00:00 UTC
Profile
CompanyAmerican Healthcare REIT, Inc.
ExchangeNYSE
TickerAHR
CIK0001632970
SICReal Estate Investment Trusts
SectorReal Estate
BusinessReal Estate
Industry groupReal Estate
IndustrySpecialized REITs
AI analysis

Business. American Healthcare REIT, Inc. is classified under Real Estate / Specialized REITs and appears profitable on the latest normalized snapshot.

Classification. Classification confidence is 0.92 based on verified market data; matched terms: Specialized REITs, Real Estate, Real Estate.

American Healthcare REIT, Inc. (AHR) is currently classified as Specialized REITs within Specialized REITs (Real Estate). Classification confidence: 0.92 (verified market data). Capital structure on the latest snapshot: total assets 5,426,226,000 USD, total equity 3,320,638,000, short-term debt 0, long-term debt 0. Net cash position is approximately 114,836,000 USD. Profitability profile: revenue 2,094,506,000, gross profit 0, operating income 415,160,000, net income 69,806,000. Return on equity ~2.1%. Return on assets ~1.3%. Operating-cash-flow to net-income ratio is 4.22. Risk profile from automated assessment: liquidity risk low, dilution risk medium. Flags: Source documents mention dilution or offering risk..
Key takeaways
  • Return on equity is about 2.1%.
  • Debt to equity is about 0.0x.
  • Public Offering and Listing On February 9, 2024, pursuant to a Registration Statement filed with the United States Securities and Exchange Commission, or SEC, on Form S-11 (File No.
Financial snapshot
PeriodFY2025
CurrencyUSD
Revenue$2.09B
Gross profit
Operating income$415.2M
Net income$69.8M
R&D
SG&A$58.7M
D&A$187.6M
SBC$14.6M
Operating cash flow$294.4M
CapEx
Free cash flow
Total assets$5.43B
Total liabilities$2.07B
Total equity$3.32B
Cash & equivalents$114.8M
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY2025$2.09B$415.2M$69.8M
FY2024$1.88B$363.5M-$37.8M
FY2025$1.88B$363.5M-$37.8M
FY2023$1.67B$306.8M-$71.5M
FY2024$1.67B$306.8M-$71.5M
PeriodGross %Op %Net %FCF %
FY2025
FY2024
FY2025
FY2023
FY2024
PeriodAssetsEquityCashDebt
FY2025$5.43B$3.32B$114.8M
FY2024$4.49B$2.26B$76.7M
FY2025$4.49B$2.26B$76.7M
FY2023$4.58B$1.27B$43.4M
FY2024$4.58B$1.27B$43.4M
PeriodOCFCapExFCFSBC
FY2025$294.4M$14.6M
FY2024$176.1M$9.9M
FY2025$176.1M$9.9M
FY2023$98.5M$5.5M
FY2024$98.5M$5.5M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
Q3 2025$1.53B$303.6M$59.0M
Q2 2025$998.5M$197.8M$3.1M
Q3 2025
Q1 2025$497.2M$94.5M-$6.8M
PeriodGross %Op %Net %FCF %
Q3 2025
Q2 2025
Q3 2025
Q1 2025
PeriodAssetsEquityCashDebt
Q3 2025$4.77B$2.68B$147.4M
Q2 2025$4.51B$2.42B$133.5M
Q3 2025$2.46B
Q1 2025$4.46B$2.26B$86.1M
PeriodOCFCapExFCFSBC
Q3 2025$239.3M$9.2M
Q2 2025$132.1M$5.7M
Q3 2025
Q1 2025$60.6M$2.6M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$3.00B
Net cash$114.8M
Current ratio
Debt/Equity0.0
ROA1.3%
ROE2.1%
Cash conversion4.2%
CapEx/Revenue
SBC/Revenue0.7%
Asset intensity
Dilution ratio
Risk assessment
Dilution riskMedium
Liquidity riskLow
  • Source documents mention dilution or offering risk.
Industry benchmarks
Activity: Specialized REITs · cohort 3 companies
MetricAHRActivity
Op margin19.8%18.9% medp25 13.4% · p75 49.5%above median
Net margin3.3%13.9% medp25 -6.1% · p75 46.4%below median
Gross margin70.1% medp25 43.3% · p75 88.7%
R&D / revenue0.1% medp25 0.1% · p75 0.1%
CapEx / revenue11.6% medp25 8.2% · p75 189.5%
Debt / equity0.0%77.3% medp25 46.7% · p75 158.8%bottom quartile
Observations
IR observations
market data ESG controversies score100.0
market data ESG governance pillar51.9
market data ESG social pillar34.7
market data insider trading score3.0
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
SEC filingstype companyfacts · CIK 0001632970 · 406 us-gaap concepts
2026-05-01 11:54 UTC#406bb74a
Source: analysis-pipeline (hybrid)Generated: 2026-05-01 11:55 UTCJob: d04e39b6